Transaction · 0001104659-26-000837

Steinhart Richard I

Steinhart Richard I, CFO, reported a transaction classified as grant at BioXcel Therapeutics, Inc. involving 70000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 70282.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACFO
BTAIBioXcel Therapeutics, Inc.
Filing timeJan 06
Trade dateJan 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.70
Pre-filing
1mo ago +21.2%1w ago +21.2%1d ago +21.2%
Returns since
7d +0.0%30d -7.1%90d -28.2%180d -18.8%1y -57.1%

BTAI price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BTAI since 2026-01-06Filed 242 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001104659-26-000837
Restricted Stock Units
Transaction date
Jan 01, 2026
Filed Jan 06, 2026, 01:01 AM · 5d delay
Shares
70.0k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
70.2k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

  2. F2

    On January 1, 2026, the Reporting Person was granted 70,000 RSUs, vesting as to 25% of the underlying shares on the six-month anniversary of the original promise date of November 4, 2025 (the "Vesting…

Original filing · 0001104659-26-000837
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BTAI